New Insights on Pharmacologic and Non-Pharmacologic Therapy of Advanced Heart Failure
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 5 June 2026 | Viewed by 18
Special Issue Editor
Interests: ventricular function; heart failure; mechanical circulatory support; heart transplantation; echocardiography; cardiac physiology; cardiac immunology; right ventricle; pulmonary hypertension
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite the important progress in the improvement of treatment strategies for patients with advanced heart failure (AHF), the incidence of cardiac decompensation episodes still remains very high and is further closely associated with worse prognosis, as well as with a poor quality of life for the affected persons.
This Special Issue aims to highlight new opportunities for early identification of patients at high risk for AHA and their optimal treatment in order to prevent the development of AHA, the further improvement of medical and device-related treatments for AHA, including the use of mechanical circulatory support systems, the optimal timing of heart transplantation (HTx) for eligible patients and the therapy of HTx candidates included on the waiting list, as well as the use of the most optimal immunosuppression and other necessary therapies for heart-transplant recipients, including the therapy of cardiac allograft rejections.
Dr. Michael Dandel
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- advanced heart failure (AHF)
- mechanical circulatory support systems
- heart transplantation (HTx)
- immunosuppression
- cardiac allograft rejections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
